The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Genome Editing/Genome Engineering Market Between 2026 And 2030?
The genome editing/genome engineering market size has experienced rapid expansion in recent years. It is anticipated to increase from $10.17 billion in 2025 to $12.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.5%. The historical growth of this market can be attributed to several factors including the discovery of genome editing techniques, their early applications in research, the increasing availability of molecular biology tools, a rise in academic research funding, and the demand for disease modeling.
The genome editing/genome engineering market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $24.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.2%. This anticipated growth during the forecast period stems from factors such as the clinical implementation of gene editing therapies, the broadening scope of agricultural genomics, advancements in editing precision, the establishment of ethical guidelines, and the increasing commercial availability of genome editing services. Key trends identified for this period encompass the wider embrace of CRISPR-based editing technologies, the extended application of genome editing in disease studies, a surge in the utilization of cell line engineering, a heightened need for precise gene alteration, and greater investment in research from academic and governmental bodies.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Genome Editing/Genome Engineering Market Expansion?
The genome editing and genome engineering market is anticipated to experience growth driven by an increase in research activities. Research activities involve systematic and structured efforts undertaken by individuals, teams, or organizations to collect, analyze, interpret, and produce new knowledge or insights in a particular academic domain. Genome editing and genome engineering have become essential enablers in the burgeoning field of research, fundamentally transforming scientific exploration. These groundbreaking tools empower scientists to precisely modify and deeply comprehend the intricate genetic blueprint of organisms, offering unparalleled exactitude and adaptability. For instance, in July 2023, according to National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH awards more than $140 million to help accelerate genome editing approaches from the lab to the clinic. Consequently, the expansion of research activities is a key force propelling the genome editing and genome engineering market.
How Are Segments Identified Within The Genome Editing/Genome Engineering Market Segment Framework?
The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And Systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects
What Trends Are Affecting The Direction Of The Genome Editing/Genome Engineering Market?
Leading companies are forming collaborations and strategic partnerships to strengthen their position within the genome editing and genome engineering market. A strategic business partnership involves a structured affiliation between two or more commercial entities, typically established through one or more business agreements or contracts. For instance, in April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company focused on developing medicines in immunology, oncology, and genetic diseases, initiated a collaboration with Mammoth Biosciences, a US-based biotech firm founded by Jennifer Doudna specializing in CRISPR-based gene editing. Through this partnership, Regeneron aims to utilize Mammoth’s ultra-small CRISPR platforms alongside Regeneron’s delivery technologies to accelerate the development of in vivo gene editing therapies for tissues beyond the liver, thereby expanding Regeneron’s therapeutic pipeline and technological reach. Mammoth Biosciences is a U.S.-based company that provides CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for therapeutic and diagnostic applications.
Who Are The Companies Competing Within The Genome Editing/Genome Engineering Market?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.
Get The Full Genome Editing/Genome Engineering Market Report:
Which Region Is The Largest In The Genome Editing/Genome Engineering Market?
North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Genome Editing/Genome Engineering Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Gene Editing Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Crispr Gene Editing Market Report 2026
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model